AIM: To investigate the clinical application of 23-gauge vitrectomy system in the treatment of vitreoretinopathy disease and evaluate its efficacy and safety.

METHODS: A retrospective study of 26 cases(26 eyes)who received 23-gauge vitrectomy from February 2012 to September 2012 was retrospectively studied. The diseases included vitreous hemorrhage(6 cases), rhegmatogenous retinal detachment(14 cases), proliferative diabetic retinopathy(5 cases)and macular epiretinal membrane(1 case). The main observation was the surgical effects and complications. The follow-up time was from 1 month to 6 months.

RESULTS: All cases were successfully completed without significant complications. The best-corrected visual acuity was improved in different degrees.

CONCLUSION: The 23-gauge vitrectomy system with better curative effect, faster postoperative recovery and few complications is an effective and safe surgical technique for all vitreoretinopathy diseases.